Pai Chen-Hsu, Hsu Jung-Chi, Lin Lian-Yu, Wang Chih-Hsien, Wei Ling-Yi, Chi Nai-Hsin, Huang Shu-Chien, Yu Hsi-Yu, Chou Nai Kuan, Hsu Ron-Bin, Chen Yih-Sharng
Division of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan.
Department of Internal Medicine, National Taiwan University Hospital, Jinshan Branch, New Taipei City, Taiwan; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Surgery. 2025 Feb;178:108928. doi: 10.1016/j.surg.2024.10.019. Epub 2024 Nov 26.
The impact of obesity on the prognosis of patients receiving venoarterial extracorporeal membrane oxygenation remains unclear. This study examines the association between body mass index and in-hospital mortality among patients on venoarterial extracorporeal membrane oxygenation support.
This retrospective study enrolled adult patients who received venoarterial extracorporeal membrane oxygenation support, which included extracorporeal cardiopulmonary resuscitation, at National Taiwan University Hospital between 2010 and 2021. Patients were classified as follows: underweight (body mass index <18.5), normal weight (18.5≤ body mass index <24), overweight (24≤ body mass index <27), class I obesity (27≤ body mass index <30), class II obesity (30≤ body mass index <35), and class III obesity (body mass index ≥35). Multivariable Cox regression with spline models was employed.
The study included 1,329 patients; of these, 670 underwent extracorporeal cardiopulmonary resuscitation, and the overall mortality rate was 61.6%. Multivariable Cox regression revealed that class III obesity was significantly associated with higher mortality (hazard ratio 2.11, 95% confidence interval 1.48-3.02, P = .001), particularly in the extracorporeal cardiopulmonary resuscitation subgroup (hazard ratio 2.71, 95% confidence interval 1.71-4.29, P < .001). No significant association was observed in the non-extracorporeal cardiopulmonary resuscitation subgroup (hazard ratio 1.29, 95% confidence interval 0.70-2.36, P = .415). Although underweight patients initially exhibited higher mortality (hazard ratio 1.77, 95% confidence interval 1.12-2.80, P = .015), this effect was attenuated after adjusting the confounders (hazard ratio 1.46, 95% confidence interval 0.91-2.35, P = .119). Kaplan-Meier analysis indicated that class III obesity was associated with the highest in-hospital mortality, followed by the underweight group (log-rank P = .009).
Obesity increased mortality in patients who underwent venoarterial extracorporeal membrane oxygenation, but this was primarily due to a nonlinear U-shaped distribution between body mass index and in-hospital mortality observed in patients receiving extracorporeal cardiopulmonary resuscitation. Further studies are needed to clarify the causal factors underlying these associations.
肥胖对接受静脉-动脉体外膜肺氧合治疗患者预后的影响尚不清楚。本研究探讨了接受静脉-动脉体外膜肺氧合支持的患者体重指数与院内死亡率之间的关联。
这项回顾性研究纳入了2010年至2021年期间在台湾大学医院接受静脉-动脉体外膜肺氧合支持(包括体外心肺复苏)的成年患者。患者分类如下:体重过轻(体重指数<18.5)、正常体重(18.5≤体重指数<24)、超重(24≤体重指数<27)、I级肥胖(27≤体重指数<30)、II级肥胖(30≤体重指数<35)和III级肥胖(体重指数≥35)。采用带样条模型的多变量Cox回归分析。
该研究纳入了1329例患者;其中670例接受了体外心肺复苏,总体死亡率为61.6%。多变量Cox回归分析显示,III级肥胖与较高死亡率显著相关(风险比2.11,95%置信区间1.48-3.02,P = 0.001),特别是在体外心肺复苏亚组中(风险比2.71,95%置信区间1.71-4.29,P < 0.001)。在非体外心肺复苏亚组中未观察到显著关联(风险比1.29,95%置信区间0.70-2.36,P = 0.415)。尽管体重过轻的患者最初死亡率较高(风险比1.77,95%置信区间1.12-2.80,P = 0.015),但在调整混杂因素后这种影响减弱(风险比1.46,95%置信区间0.91-2.35,P = 0.119)。Kaplan-Meier分析表明,III级肥胖与最高的院内死亡率相关,其次是体重过轻组(对数秩检验P = 0.009)。
肥胖增加了接受静脉-动脉体外膜肺氧合治疗患者的死亡率,但这主要是由于在接受体外心肺复苏的患者中观察到体重指数与院内死亡率之间呈非线性U形分布。需要进一步研究以阐明这些关联背后的因果因素。